George V. Migausky, Director at Immunovant, Inc. (IMVT), sold 21,200 shares at $39.81 ($846K) on 2023-12-01, disclosed to the SEC on 2023-12-05.
Scheduled sale ($846k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.79 | 4,200 | $163K | 19.3% |
| 2 | $39.81 | 3,478 | $138K | 16.4% |
| 3 | $39.81 | 3,478 | $138K | 16.4% |
| 4 | $40.46 | 5,022 | $203K | 24.0% |
| 5 | $40.46 | 5,022 | $203K | 24.0% |
| Total | $39.92 avg | 21,200 |
| $846K |
| 100% |
| Filing → |
| DYAX | SELL | 2015-03-06 | $79K | — | Filing → |
| DYAX | SELL | 2015-02-26 | $141K | — | Filing → |
| DYAX | SELL | 2014-06-17 | $132K | — | Filing → |